세계의 바이오의약품 발효 시스템 시장 보고서(2025년)

Biopharmaceutical Fermentation Systems Global Market Report 2025

US $ 4,490 ￦ 6,339,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,163,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,987,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

바이오의약품 발효 시스템 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 9.3%의 연평균 복합 성장률(CAGR)로 383억 9,000만 달러에 달할 것으로 예측됩니다. 예측 기간 동안의 성장은 바이오 의약품 파이프라인의 확대, 개인 맞춤형 의료로의 전환, 연속 바이오프로세스의 채택, 신흥 시장 확대, 자동화 및 디지털화의 발전에 기인하는 것으로 보입니다. 예측 기간 동안 주요 동향으로는 연속 생산의 채택 확대, 개인 맞춤형 의료의 성장, 바이오시밀러 시장 확대, 고급 분석 및 AI 채택, 지속가능성 및 환경 영향에 대한 강조 등이 있습니다.

바이오의약품 파이프라인의 확대가 향후 몇 년간 바이오의약품 발효 시스템 시장의 성장을 견인할 것으로 예측됩니다. 바이오의약품에는 백신, 유전자 치료제, 재조합 치료용 단백질 등 생물체 또는 그 구성 요소에서 유래한 의약품이 포함됩니다. 이러한 바이오의약품 파이프라인의 성장은 생명공학 기술의 발전, 질병 메커니즘에 대한 더 깊은 통찰력, 표적치료 및 맞춤치료에 대한 수요 증가에 의해 촉진되고 있습니다. 바이오의약품 발효 시스템은 유전자 조작된 세포와 미생물을 배양하여 복잡한 치료용 단백질, 항체, 백신을 대규모로 합성할 수 있게 함으로써 바이오의약품 생산에 중요한 역할을 하고 있습니다. 예를 들어, 2023년 미국 식품의약국(FDA)은 29개의 신규 화학물질(NCE)과 25개의 신규 생물학적 제제(NBE)를 포함한 55개의 신약을 승인하여 2022년의 37개 승인에 비해 50% 증가하였습니다. 따라서 생물학적 제제 파이프라인의 성장이 바이오의약품 발효 시스템 시장을 견인하고 있습니다.

생물학적 제제 발효 시스템 시장의 주요 업체들은 효율성, 확장성, 재현성을 향상시키기 위해 자동 바이오리액터와 같은 첨단 시스템 개발에 주력하고 있습니다. 자동 바이오리액터는 바이오의약품 제조에서 미생물 및 세포의 증식 조건을 최적화하기 위한 자동 제어 및 모니터링 기술을 통합한 것입니다. 예를 들어, 프랑스에 본사를 둔 실험기기 제조업체인 포일라보(Foilabo)는 2022년 10월 완전 자동화된 실험실 규모 바이오리액터를 출시하였습니다. 이 바이오리액터는 다양한 용도에 대응할 수 있는 범용성과 정확성을 갖추고 있으며, 임펠러의 배치와 유형을 사용자 정의할 수 있는 옵션으로 고품격 무균 상태를 제공합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계 바이오의약품 발효 시스템 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업 분석
• 세계의 바이오의약품 발효 시스템 시장 : 성장률 분석
• 세계의 바이오의약품 발효 시스템 시장 실적 : 규모와 성장, 2019-2024
• 세계의 바이오의약품 발효 시스템 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계 바이오의약품 발효 시스템 전체 시장(TAM)

제6장 시장 세분화

• 세계의 바이오의약품 발효 시스템 시장 : 제품별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• Upstream 제품
• Downstream 제품
• 세계의 바이오의약품 발효 시스템 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 재조합 단백질
• 단일클론항체
• 항생제
• 프로바이오틱스
• 기타 용도
• 세계의 바이오의약품 발효 시스템 시장 : 최종사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 바이오의약품 기업
• 계약 제조 조직
• 계약연구기관
• 학술연구기관
• 식품 업계
• 기타 최종사용자
• 세계의 바이오의약품 발효 시스템 시장 Upstream 제품 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 발효조 또는 바이오리액터
• 문화 미디어
• 접종물 조제 시스템
• 가스 및 액체 유량 제어 시스템
• 프로세스 모니터링 및 제어 시스템
• 멸균 시스템
• 세계의 바이오의약품 발효 시스템 시장 Downstream 제품 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 여과 시스템
• 원심분리기
• 크로마토그래피 시스템
• 한외여과 시스템 및 정밀여과 시스템
• 농축 및 정제 시스템
• 포장 및 보관 시스템

제7장 지역별/국가별 분석

• 세계의 바이오의약품 발효 시스템 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 바이오의약품 발효 시스템 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 바이오의약품 발효 시스템 시장 : 경쟁 구도
• 바이오의약품 발효 시스템 시장 : 기업 개요
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 3M Company Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업 및 혁신 기업

• Becton Dickinson and Company
• GE Healthcare
• Agilent Technologies Inc.
• Lonza Group AG
• GEA Group AG
• Sartorius Stedim Biotech
• Bio-Rad Laboratories Inc.
• Pall Corporation
• Nova Biomedical
• Eppendorf AG
• Repligen Corporation
• ZETA Holding GmbH
• New Brunswick Scientific
• ABEC Inc.
• Pierre Guerin Technologies

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 바이오의약품 발효 시스템 시장(2029년) : 새로운 기회를 제공하는 국가
• 바이오의약품 발효 시스템 시장(2029년) : 새로운 기회를 제공하는 부문
• 바이오의약품 발효 시스템 시장(2029년) : 성장 전략
  • 시장 동향에 근거한 전략
  • 경쟁 전략

제36장 부록

LSH

영문 목차

영문목차

A biopharmaceutical fermentation system is a specialized arrangement designed to cultivate microorganisms or cells for the production of biopharmaceutical products in controlled environments. These systems are crucial in the biomanufacturing process, facilitating the generation of biologically active compounds such as proteins, antibodies, vaccines, and other therapeutic agents. Key components of biopharmaceutical fermentation systems include bioreactors or fermenters, which create optimal conditions for cell growth and product formation by regulating factors such as temperature, pH, oxygen levels, and nutrient availability.

The primary products of biopharmaceutical fermentation systems can be categorized into upstream and downstream products. Upstream products encompass materials, equipment, or processes involved in the initial production stages, focusing on raw materials, cultivation, and early manufacturing processes. These systems find applications in producing various substances such as recombinant proteins, monoclonal antibodies, antibiotics, probiotics, among others. End-users of these products include biopharmaceutical companies, contract manufacturing organizations, contract research organizations, academic research institutes, the food industry, and other relevant sectors.

The biopharmaceutical fermentation systems market research report is one of a series of new reports from The Business Research Company that provides biopharmaceutical fermentation systems market statistics, including biopharmaceutical fermentation systems industry global market size, regional shares, competitors with biopharmaceutical fermentation systems market share, detailed biopharmaceutical fermentation systems market segments, market trends, and opportunities, and any further data you may need to thrive in the biopharmaceutical fermentation systems industry. This biopharmaceutical fermentation systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The biopharmaceutical fermentation systems market size has grown strongly in recent years. It will grow from $24.61 billion in 2024 to $26.86 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to increasing demand for biologics, regulatory support, industry consolidation, growing investment in research and developments, and evolving healthcare landscape.

The biopharmaceutical fermentation systems market size is expected to see strong growth in the next few years. It will grow to $38.39 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to expansion of biopharmaceutical pipeline, shift towards personalized medicine, adoption of continuous bioprocessing, emerging market expansion, and advancements in automation and digitalization. Major trends in the forecast period include increased adoption of continuous manufacturing, growth in personalized medicine, expansion of biosimilars market, adoption of advanced analytics and AI, and focus on sustainability and environmental impact.

The expansion of the biologics pipeline is set to drive the growth of the biopharmaceutical fermentation systems market in the coming years. Biologics encompass medicinal products derived from living organisms or their components, including vaccines, gene therapies, and recombinant therapeutic proteins. This growth in the biologics pipeline is fueled by advancements in biotechnology, deeper insights into disease mechanisms, and the increasing demand for targeted and personalized therapies. Biopharmaceutical fermentation systems play a crucial role in biologics production by cultivating genetically engineered cells or microorganisms, enabling the large-scale synthesis of complex therapeutic proteins, antibodies, and vaccines. For example, in 2023, the Food and Drug Administration (FDA) approved 55 new drugs, including 29 new chemical entities (NCEs) and 25 new biological entities (NBEs), marking a 50% increase compared to the 37 approvals in 2022. Hence, the growing biologics pipeline is propelling the biopharmaceutical fermentation systems market forward.

Key players in the biologics fermentation systems market are focusing on developing advanced systems such as automated bioreactors to improve efficiency, scalability, and reproducibility. Automated bioreactors integrate automated control and monitoring technologies to optimize growth conditions for microorganisms or cells in biopharmaceutical production. For instance, Froilabo, a France-based laboratory equipment company, launched fully automated lab-scale bioreactors in October 2022. These bioreactors offer versatility and precision for various applications, providing high-grade aseptic conditions with customizable options for impeller placement and type.

In December 2022, MilliporeSigma, a US-based life sciences company, acquired Erbi Biosystems Inc., enhancing its upstream portfolio in therapeutic proteins. This acquisition integrated Erbi Biosystems' Breez micro-bioreactor platform technology, facilitating scalable cell-based perfusion bioreactor processes from 2ml to 2000L and promoting innovation in continuous bioprocessing. Erbi Biosystems Inc. is a US-based company specializing in bioprocess instrumentation for cell therapy and bioprocessing process development.

Major companies operating in the biopharmaceutical fermentation systems market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., 3M Company, Danaher Corporation, Merck KGaA, Becton Dickinson and Company, GE Healthcare, Agilent Technologies Inc., Lonza Group AG, GEA Group AG, Sartorius Stedim Biotech, Bio-Rad Laboratories Inc., Pall Corporation, Nova Biomedical, Eppendorf AG, Repligen Corporation, ZETA Holding GmbH, New Brunswick Scientific, ABEC Inc., Pierre Guerin Technologies, AntoXa Corporation, Applikon Biotechnology, Cellexus Ltd., Infors HT, BioPharm Process Associates LLC

North America was the largest region in the biopharmaceutical fermentation systems market in 2024. The regions covered in the biopharmaceutical fermentation systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biopharmaceutical fermentation systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biopharmaceutical fermentation system market consists of revenues earned by entities by providing services such as analytical services, maintenance services, regulatory support, contract manufacturing, and integration services. The market value includes the value of related goods sold by the service provider or included within the service offering. The biopharmaceutical fermentation systems market also includes sales of bioreactors, media and buffers, and microorganisms and cell lines which are used in providing the services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biopharmaceutical Fermentation Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biopharmaceutical fermentation systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biopharmaceutical fermentation systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biopharmaceutical fermentation systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Upstream Products; Downstream Products
• 2) By Application: Recombinant Proteins; Monoclonal Antibodies; Antibiotics; Probiotics; Other Applications
• 3) By End-User: Biopharmaceutical Companies; Contract Manufacturing Organizations; Contract Research Organizations; Academic Research Institutes; Food Industry; Other End-Users
• Subsegments:
• 1) By Upstream Products: Fermenters Or Bioreactors; Culture Media; Inoculum Preparation Systems; Gas And Liquid Flow Control Systems; Process Monitoring And Control Systems; Sterilization Systems
• 2) By Downstream Products: Filtration Systems; Centrifuges; Chromatography Systems; Ultrafiltration And Microfiltration Systems; Concentration And Purification Systems; Packaging And Storage Systems
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; 3M Company; Danaher Corporation; Merck KGaA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biopharmaceutical Fermentation Systems Market Characteristics

3. Biopharmaceutical Fermentation Systems Market Trends And Strategies

4. Biopharmaceutical Fermentation Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Biopharmaceutical Fermentation Systems Growth Analysis And Strategic Analysis Framework

• 5.1. Global Biopharmaceutical Fermentation Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Biopharmaceutical Fermentation Systems Market Growth Rate Analysis
• 5.4. Global Biopharmaceutical Fermentation Systems Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Biopharmaceutical Fermentation Systems Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Biopharmaceutical Fermentation Systems Total Addressable Market (TAM)

6. Biopharmaceutical Fermentation Systems Market Segmentation

• 6.1. Global Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Upstream Products
• Downstream Products
• 6.2. Global Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Recombinant Proteins
• Monoclonal Antibodies
• Antibiotics
• Probiotics
• Other Applications
• 6.3. Global Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biopharmaceutical Companies
• Contract Manufacturing Organizations
• Contract Research Organizations
• Academic Research Institutes
• Food Industry
• Other End-Users
• 6.4. Global Biopharmaceutical Fermentation Systems Market, Sub-Segmentation Of Upstream Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fermenters Or Bioreactors
• Culture Media
• Inoculum Preparation Systems
• Gas And Liquid Flow Control Systems
• Process Monitoring And Control Systems
• Sterilization Systems
• 6.5. Global Biopharmaceutical Fermentation Systems Market, Sub-Segmentation Of Downstream Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Filtration Systems
• Centrifuges
• Chromatography Systems
• Ultrafiltration And Microfiltration Systems
• Concentration And Purification Systems
• Packaging And Storage Systems

7. Biopharmaceutical Fermentation Systems Market Regional And Country Analysis

• 7.1. Global Biopharmaceutical Fermentation Systems Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Biopharmaceutical Fermentation Systems Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biopharmaceutical Fermentation Systems Market

• 8.1. Asia-Pacific Biopharmaceutical Fermentation Systems Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biopharmaceutical Fermentation Systems Market

• 9.1. China Biopharmaceutical Fermentation Systems Market Overview
• 9.2. China Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biopharmaceutical Fermentation Systems Market

• 10.1. India Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biopharmaceutical Fermentation Systems Market

• 11.1. Japan Biopharmaceutical Fermentation Systems Market Overview
• 11.2. Japan Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biopharmaceutical Fermentation Systems Market

• 12.1. Australia Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biopharmaceutical Fermentation Systems Market

• 13.1. Indonesia Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biopharmaceutical Fermentation Systems Market

• 14.1. South Korea Biopharmaceutical Fermentation Systems Market Overview
• 14.2. South Korea Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biopharmaceutical Fermentation Systems Market

• 15.1. Western Europe Biopharmaceutical Fermentation Systems Market Overview
• 15.2. Western Europe Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biopharmaceutical Fermentation Systems Market

• 16.1. UK Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biopharmaceutical Fermentation Systems Market

• 17.1. Germany Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biopharmaceutical Fermentation Systems Market

• 18.1. France Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biopharmaceutical Fermentation Systems Market

• 19.1. Italy Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biopharmaceutical Fermentation Systems Market

• 20.1. Spain Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biopharmaceutical Fermentation Systems Market

• 21.1. Eastern Europe Biopharmaceutical Fermentation Systems Market Overview
• 21.2. Eastern Europe Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biopharmaceutical Fermentation Systems Market

• 22.1. Russia Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biopharmaceutical Fermentation Systems Market

• 23.1. North America Biopharmaceutical Fermentation Systems Market Overview
• 23.2. North America Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biopharmaceutical Fermentation Systems Market

• 24.1. USA Biopharmaceutical Fermentation Systems Market Overview
• 24.2. USA Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biopharmaceutical Fermentation Systems Market

• 25.1. Canada Biopharmaceutical Fermentation Systems Market Overview
• 25.2. Canada Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biopharmaceutical Fermentation Systems Market

• 26.1. South America Biopharmaceutical Fermentation Systems Market Overview
• 26.2. South America Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biopharmaceutical Fermentation Systems Market

• 27.1. Brazil Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biopharmaceutical Fermentation Systems Market

• 28.1. Middle East Biopharmaceutical Fermentation Systems Market Overview
• 28.2. Middle East Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biopharmaceutical Fermentation Systems Market

• 29.1. Africa Biopharmaceutical Fermentation Systems Market Overview
• 29.2. Africa Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biopharmaceutical Fermentation Systems Market Competitive Landscape And Company Profiles

• 30.1. Biopharmaceutical Fermentation Systems Market Competitive Landscape
• 30.2. Biopharmaceutical Fermentation Systems Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. 3M Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

31. Biopharmaceutical Fermentation Systems Market Other Major And Innovative Companies

• 31.1. Becton Dickinson and Company
• 31.2. GE Healthcare
• 31.3. Agilent Technologies Inc.
• 31.4. Lonza Group AG
• 31.5. GEA Group AG
• 31.6. Sartorius Stedim Biotech
• 31.7. Bio-Rad Laboratories Inc.
• 31.8. Pall Corporation
• 31.9. Nova Biomedical
• 31.10. Eppendorf AG
• 31.11. Repligen Corporation
• 31.12. ZETA Holding GmbH
• 31.13. New Brunswick Scientific
• 31.14. ABEC Inc.
• 31.15. Pierre Guerin Technologies

32. Global Biopharmaceutical Fermentation Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biopharmaceutical Fermentation Systems Market

34. Recent Developments In The Biopharmaceutical Fermentation Systems Market

35. Biopharmaceutical Fermentation Systems Market High Potential Countries, Segments and Strategies

• 35.1 Biopharmaceutical Fermentation Systems Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Biopharmaceutical Fermentation Systems Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Biopharmaceutical Fermentation Systems Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료